Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs > Sunshine Biopharma Inc. (SBFM)

BEST all in one DD I have seen

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 221
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/19/2014 4:01:04 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/12/2014 7:01:12 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/12/2014 5:26:36 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/28/2014 4:05:06 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/24/2014 6:01:50 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 7/3/2014 6:02:21 AM
Sunshine Biopharma's Adva-27a Featured in 2014 Worldwide Uterine Cancer Report for Its Effectiveness Against Multidrug Resist... "Marketwired" - 6/9/2014 8:00:00 AM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 5/22/2014 4:48:18 PM
Sunshine Biopharma Announces Issuance of Notice of Allowance for the Patent Application Covering Adva-27a Anticancer Compound... "Marketwired" - 5/12/2014 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/9/2014 12:46:44 PM
Sunshine Biopharma Secures Funding for Its Adva-27a Anticancer Compound From Dutchess Opportunity Fund II "Marketwired" - 4/29/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/28/2014 4:35:24 PM
Sunshine Biopharma Increases the Effectiveness of Adva-27a Lead Compound 9.5-Fold Against Breast and Pancreatic Cancer in Vitro "Marketwired" - 4/7/2014 8:00:00 AM
Management of Sunshine Biopharma Alarmed by the Recent World Health Organization Report That Cancer Is on the Rise "Marketwired" - 3/31/2014 8:00:00 AM
Definitive Materials Filed by Investment Companies. (497) "Edgar (US Regulatory)" - 3/19/2014 4:41:46 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/19/2014 4:39:10 PM
Sunshine Biopharma Begins Construction of Mouse Xenograft Models for Pancreatic Cancer to Advance Adva-27a as a Treatment for... "Marketwired" - 2/14/2014 8:00:00 AM
Sunshine Biopharma Continues Its Efforts to Re-Domicile in Canada for Bus. Expansion & Financing Opportunities for Adva-27a C... "Marketwired" - 2/4/2014 8:00:00 AM
Sunshine Biopharma Targets Pancreatic Cancer as Second Indication for Clinical Trials of Adva-27a Compound "Marketwired" - 1/21/2014 8:07:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist